Understanding how a specific protein affects Fragile X Syndrome
Elucidating Fragile X Syndrome by Investigating FMRP Molecular Function
This study is looking at how a protein called FMRP, which is important for people with Fragile X Syndrome, works in the brain to help control how proteins are made, with the hope of finding new treatments to ease the symptoms of this condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10726851 on NIH RePORTER |
What this research studies
This research investigates the molecular function of FMRP, a protein linked to Fragile X Syndrome, which is the most common inherited cause of intellectual impairment and autism. By studying FMRP's interactions with mRNA in the brain, the research aims to uncover how it regulates protein synthesis and contributes to the symptoms of Fragile X. Using Fmr1 knockout mice as a model, the team will explore the mechanisms behind FMRP's role in translational stalling, which could lead to new therapeutic strategies. The ultimate goal is to identify potential small-molecule treatments that could alleviate the symptoms of this disorder.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Fragile X Syndrome, particularly children who exhibit symptoms such as developmental delays and aggression.
Not a fit: Patients without a diagnosis of Fragile X Syndrome or those with unrelated developmental disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the quality of life for individuals with Fragile X Syndrome.
How similar studies have performed: Previous research has shown promise in understanding the molecular mechanisms of FMRP, but this specific approach focusing on translational stalling is relatively novel.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Richter, Joel D — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Richter, Joel D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.